10 20 30 40 50 60 70 80 2JT8 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER STRUCTURAL PROTEIN 20-JUL-07 2JT8
TITLE SOLUTION STRUCTURE OF THE F153-TO-5-FLUROTRYPTOPHAN MUTANT TITLE 2 OF HUMAN CARDIAC TROPONIN C
COMPND MOL_ID: 1; COMPND 2 MOLECULE: TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TN-C; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNNC1, TNNC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: (DE3)PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PET-21
KEYWDS EF-HAND PROTEIN, CALCIUM-BIND PROTEIN, PHE-TO-TRP MUTATION, KEYWDS 2 ACETYLATION, MUSCLE PROTEIN, POLYMORPHISM, STRUCTURAL KEYWDS 3 PROTEIN
EXPDTA SOLUTION NMR
NUMMDL 10
AUTHOR X.WANG,P.MERCIER,P.LETOURNEAU,B.D.SYKES
REVDAT 2 24-FEB-09 2JT8 1 VERSN REVDAT 1 07-AUG-07 2JT8 0
JRNL AUTH X.WANG,P.MERCIER,P.LETOURNEAU,B.SYKES JRNL TITL EFFECTS OF PHE-TO-TRP MUTATION AND JRNL TITL 2 FLUOROTRYPTOPHAN INCORPORATION ON THE SOLUTION JRNL TITL 3 STRUCTURE OF CARDIAC TROPONIN C, AND ANALYSIS OF JRNL TITL 4 ITS SUITABILITY AS A POTENTIAL PROBE FOR IN SITU JRNL TITL 5 NMR STUDIES JRNL REF PROTEIN SCI. V. 14 2447 2005 JRNL REFN ISSN 0961-8368 JRNL PMID 16131667 JRNL DOI 10.1110/PS.051595805
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2JT8 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JUL-07. REMARK 100 THE RCSB ID CODE IS RCSB100260.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.0 MM F153(FTR), 10 MM REMARK 210 CALCIUM, 100 MM POTASSIUM REMARK 210 CHLORIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC, 3D 1H-15N REMARK 210 NOESY, 3D 1H-13C NOESY, 3D REMARK 210 HNCACB, 3D CBCA(CO)NH, 3D HCCH REMARK 210 -TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW, CYANA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 2 155.82 64.65 REMARK 500 1 ILE A 4 -36.83 -164.54 REMARK 500 1 LYS A 39 103.86 -51.87 REMARK 500 1 THR A 53 -58.90 178.88 REMARK 500 1 ASP A 65 103.30 -52.14 REMARK 500 1 SER A 84 84.83 56.66 REMARK 500 1 LYS A 86 -75.49 69.21 REMARK 500 1 ASP A 88 170.27 61.40 REMARK 500 1 SER A 89 -35.10 -179.36 REMARK 500 1 LYS A 90 -170.30 -173.16 REMARK 500 1 LYS A 92 165.32 63.02 REMARK 500 1 ALA A 123 75.06 -116.68 REMARK 500 1 THR A 124 -37.47 -176.04 REMARK 500 1 LYS A 142 -39.33 -162.31 REMARK 500 1 ASN A 144 87.33 63.64 REMARK 500 1 ASP A 145 -40.20 -160.46 REMARK 500 1 ASP A 151 -34.26 -179.56 REMARK 500 2 LYS A 39 103.20 -51.76 REMARK 500 2 GLN A 50 -177.13 -64.44 REMARK 500 2 THR A 53 -58.93 178.82 REMARK 500 2 SER A 84 -170.27 59.11 REMARK 500 2 LYS A 86 179.85 61.10 REMARK 500 2 SER A 89 53.40 -173.92 REMARK 500 2 LYS A 90 162.57 63.22 REMARK 500 2 LYS A 92 46.66 -102.35 REMARK 500 2 SER A 93 -169.95 -113.83 REMARK 500 2 ALA A 123 66.98 -109.45 REMARK 500 2 THR A 124 28.80 -165.88 REMARK 500 2 GLU A 126 87.45 52.12 REMARK 500 2 ASP A 149 -168.53 -106.43 REMARK 500 2 ASP A 151 -36.40 -174.57 REMARK 500 2 MET A 157 63.37 -109.83 REMARK 500 3 SER A 37 -74.07 -151.53 REMARK 500 3 THR A 53 -58.98 178.91 REMARK 500 3 GLU A 63 57.71 -119.61 REMARK 500 3 ASP A 65 103.49 -51.84 REMARK 500 3 MET A 85 56.43 -109.74 REMARK 500 3 LYS A 86 -34.74 -179.48 REMARK 500 3 ASP A 88 98.97 -179.12 REMARK 500 3 LYS A 92 -173.58 -68.61 REMARK 500 3 GLU A 126 -179.51 -57.81 REMARK 500 3 THR A 127 67.72 -105.27 REMARK 500 3 ASP A 141 173.62 -53.76 REMARK 500 3 LYS A 142 -40.43 -158.61 REMARK 500 3 ASN A 143 -79.68 -67.36 REMARK 500 3 ASN A 144 -33.16 176.03 REMARK 500 3 ASP A 149 -166.71 -117.39 REMARK 500 3 LYS A 158 105.08 63.25 REMARK 500 4 ASP A 2 159.17 63.71 REMARK 500 4 LYS A 39 -126.41 65.95 REMARK 500 4 GLN A 50 -179.14 -57.67 REMARK 500 4 THR A 53 -58.78 178.95 REMARK 500 4 VAL A 64 -39.68 -130.83 REMARK 500 4 ASP A 65 104.14 -52.76 REMARK 500 4 PHE A 74 -70.35 -59.30 REMARK 500 4 SER A 84 -74.40 -86.09 REMARK 500 4 ASP A 88 117.67 -167.35 REMARK 500 4 SER A 89 -34.98 -179.43 REMARK 500 4 LYS A 90 166.11 63.15 REMARK 500 4 GLU A 126 -169.25 50.97 REMARK 500 4 ASP A 151 -41.88 -165.86 REMARK 500 5 ASP A 2 54.18 -114.81 REMARK 500 5 ALA A 31 -168.04 -60.11 REMARK 500 5 SER A 37 159.83 -46.08 REMARK 500 5 LYS A 39 101.59 -50.61 REMARK 500 5 THR A 53 -58.88 178.86 REMARK 500 5 ASP A 65 78.33 -102.06 REMARK 500 5 SER A 69 -42.04 -149.53 REMARK 500 5 SER A 84 -175.55 57.31 REMARK 500 5 MET A 85 39.38 -153.75 REMARK 500 5 LYS A 90 164.64 63.24 REMARK 500 5 GLU A 126 -75.43 -50.09 REMARK 500 5 THR A 127 82.81 178.33 REMARK 500 5 LYS A 142 -39.86 -157.65 REMARK 500 5 ASN A 143 -78.05 -64.77 REMARK 500 5 ASN A 144 -32.80 176.52 REMARK 500 5 ASP A 149 -166.28 -101.34 REMARK 500 5 ASP A 151 -36.07 -175.36 REMARK 500 6 ILE A 4 -40.19 78.02 REMARK 500 6 LYS A 39 106.39 -53.11 REMARK 500 6 GLN A 50 96.71 59.02 REMARK 500 6 THR A 53 -58.86 178.91 REMARK 500 6 VAL A 64 -40.17 -130.10 REMARK 500 6 SER A 84 -75.64 69.40 REMARK 500 6 MET A 85 73.44 63.47 REMARK 500 6 LYS A 86 -34.79 -179.29 REMARK 500 6 ASP A 88 -68.13 -143.56 REMARK 500 6 SER A 89 163.18 63.20 REMARK 500 6 SER A 93 -169.84 -120.15 REMARK 500 6 THR A 124 -40.94 -159.64 REMARK 500 6 THR A 127 73.20 -115.62 REMARK 500 6 ASP A 151 -34.04 179.99 REMARK 500 7 ILE A 4 26.62 46.42 REMARK 500 7 SER A 35 92.50 -64.38 REMARK 500 7 ILE A 36 128.99 -174.52 REMARK 500 7 SER A 37 -74.32 -177.97 REMARK 500 7 GLN A 50 105.14 63.34 REMARK 500 7 THR A 53 -58.85 178.94 REMARK 500 7 ASP A 65 95.01 -68.43 REMARK 500 7 PHE A 74 -74.05 -65.22 REMARK 500 7 LYS A 86 43.80 37.66 REMARK 500 7 GLU A 126 -176.47 -61.58 REMARK 500 7 ASP A 141 109.87 -51.50 REMARK 500 7 ASP A 151 -33.43 179.13 REMARK 500 7 LYS A 158 -75.87 -53.58 REMARK 500 8 ASP A 2 -50.09 -165.87 REMARK 500 8 SER A 37 -60.92 -179.32 REMARK 500 8 GLN A 50 101.89 62.25 REMARK 500 8 THR A 53 -58.86 178.93 REMARK 500 8 ASP A 65 105.49 -52.07 REMARK 500 8 MET A 85 91.75 62.28 REMARK 500 8 LYS A 86 59.58 -146.25 REMARK 500 8 SER A 89 -76.07 69.12 REMARK 500 8 LYS A 90 92.24 56.26 REMARK 500 8 LYS A 92 29.62 -167.46 REMARK 500 8 GLU A 126 -76.69 -41.36 REMARK 500 8 THR A 127 27.70 -166.80 REMARK 500 8 ASP A 141 -161.86 -100.38 REMARK 500 8 ASN A 144 26.77 -178.94 REMARK 500 8 ASP A 145 -4.27 -142.64 REMARK 500 8 ASP A 151 -37.72 -171.10 REMARK 500 9 ASP A 2 -170.98 -172.80 REMARK 500 9 ILE A 4 30.79 39.95 REMARK 500 9 TYR A 5 -69.53 -127.39 REMARK 500 9 SER A 37 24.28 -153.87 REMARK 500 9 LYS A 39 -116.99 59.30 REMARK 500 9 GLU A 40 -64.29 -95.92 REMARK 500 9 GLN A 50 170.05 -52.14 REMARK 500 9 THR A 53 -58.93 178.85 REMARK 500 9 GLU A 63 71.97 -114.93 REMARK 500 9 ASP A 65 102.90 -53.10 REMARK 500 9 PHE A 74 -73.56 -61.56 REMARK 500 9 MET A 85 -35.91 -175.13 REMARK 500 9 ASP A 88 -170.02 -179.18 REMARK 500 9 SER A 89 163.75 63.19 REMARK 500 9 LYS A 90 142.88 -173.86 REMARK 500 9 LYS A 92 63.70 -179.29 REMARK 500 9 ASP A 105 87.19 -68.24 REMARK 500 9 ALA A 123 -70.15 -58.47 REMARK 500 9 GLU A 126 -75.95 -51.45 REMARK 500 9 THR A 127 77.28 -168.99 REMARK 500 9 ASN A 144 80.69 63.42 REMARK 500 9 ASP A 145 -40.78 -150.35 REMARK 500 10 ASP A 2 -34.98 -179.18 REMARK 500 10 SER A 37 26.28 -158.60 REMARK 500 10 LYS A 39 64.42 -173.33 REMARK 500 10 THR A 53 -58.89 178.89 REMARK 500 10 ASP A 65 102.85 -52.66 REMARK 500 10 MET A 85 -34.35 -179.46 REMARK 500 10 LYS A 86 178.84 58.04 REMARK 500 10 THR A 124 -65.75 -167.40 REMARK 500 10 GLU A 126 -70.50 71.62 REMARK 500 10 THR A 127 28.07 -167.51 REMARK 500 10 ASN A 143 -77.66 -67.28 REMARK 500 10 ASN A 144 -36.68 175.38 REMARK 500 10 ASP A 151 -36.42 -175.99 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15400 RELATED DB: BMRB
DBREF 2JT8 A 1 161 UNP P63316 TNNC1_HUMAN 1 161
SEQADV 2JT8 SER A 35 UNP P63316 CYS 35 ENGINEERED SEQADV 2JT8 SER A 84 UNP P63316 CYS 84 ENGINEERED SEQADV 2JT8 FTR A 153 UNP P63316 PHE 153 ENGINEERED
SEQRES 1 A 161 MET ASP ASP ILE TYR LYS ALA ALA VAL GLU GLN LEU THR SEQRES 2 A 161 GLU GLU GLN LYS ASN GLU PHE LYS ALA ALA PHE ASP ILE SEQRES 3 A 161 PHE VAL LEU GLY ALA GLU ASP GLY SER ILE SER THR LYS SEQRES 4 A 161 GLU LEU GLY LYS VAL MET ARG MET LEU GLY GLN ASN PRO SEQRES 5 A 161 THR PRO GLU GLU LEU GLN GLU MET ILE ASP GLU VAL ASP SEQRES 6 A 161 GLU ASP GLY SER GLY THR VAL ASP PHE ASP GLU PHE LEU SEQRES 7 A 161 VAL MET MET VAL ARG SER MET LYS ASP ASP SER LYS GLY SEQRES 8 A 161 LYS SER GLU GLU GLU LEU SER ASP LEU PHE ARG MET PHE SEQRES 9 A 161 ASP LYS ASN ALA ASP GLY TYR ILE ASP LEU ASP GLU LEU SEQRES 10 A 161 LYS ILE MET LEU GLN ALA THR GLY GLU THR ILE THR GLU SEQRES 11 A 161 ASP ASP ILE GLU GLU LEU MET LYS ASP GLY ASP LYS ASN SEQRES 12 A 161 ASN ASP GLY ARG ILE ASP TYR ASP GLU FTR LEU GLU PHE SEQRES 13 A 161 MET LYS GLY VAL GLU
MODRES 2JT8 FTR A 153 TRP FLUOROTRYPTOPHANE
HET FTR A 153 24
HETNAM FTR FLUOROTRYPTOPHANE
FORMUL 1 FTR C11 H11 F N2 O2
HELIX 1 1 ILE A 4 LEU A 12 1 9 HELIX 2 2 GLU A 15 PHE A 20 1 6 HELIX 3 3 PHE A 20 VAL A 28 1 9 HELIX 4 4 GLU A 40 MET A 47 1 8 HELIX 5 5 THR A 53 GLU A 63 1 11 HELIX 6 6 ASP A 73 SER A 84 1 12 HELIX 7 7 SER A 93 ASP A 105 1 13 HELIX 8 8 ASP A 113 LYS A 118 1 6 HELIX 9 9 LYS A 118 ALA A 123 1 6 HELIX 10 10 ASP A 132 ASP A 141 1 10 HELIX 11 11 ASP A 151 MET A 157 1 7
LINK C GLU A 152 N FTR A 153 1555 1555 1.33 LINK C FTR A 153 N LEU A 154 1555 1555 1.33
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000